Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types

被引:333
作者
Dumoutier, L
Leemans, C
Lejeune, D
Kotenko, SV
Renauld, JC
机构
[1] Ludwig Inst Canc Res, Brussels Branch, B-1200 Brussels, Belgium
[2] Univ Louvain, Christian de Duve Inst Cellular Pathol, Expt Med Unit, Brussels, Belgium
[3] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA
关键词
D O I
10.4049/jimmunol.167.7.3545
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-10-related cytokines include IL-20 and IL-22, which induce, respectively, keratinocyte proliferation and acute phase production by hepatocytes, as well as IL-19, melanoma differentiation-associated gene 7, and AK155, three cytokines for which no activity nor receptor complex has been described thus far. Here, we show that mda-7 and IL-19 bind to the previously described IL-20R complex, composed by cytokine receptor family 2-8/IL-20R alpha and DIRS1/IL-20R beta (type I IL-20R). In addition, mda-7 and IL-20, but not IL-19, bind to another receptor complex, composed by IL-22R and DIRS1/ IL20R beta (type II IL-20R). In both cases, binding of the ligands results in STAT3 phosphorylation and activation of a minimal promoter including STAT-binding sites. Taken together, these results demonstrate that: 1) IL-20 induces STAT activation through IL-20R complexes of two types; 2) mda-7 and IL-20 redundantly signal through both complexes; and 3) IL-19 signals only through the type I IL-20R complex.
引用
收藏
页码:3545 / 3549
页数:5
相关论文
共 17 条
  • [1] Interleukin 20: Discovery, receptor identification, and role in epidermal function
    Blumberg, H
    Conklin, D
    Xu, WF
    Grossmann, A
    Brender, T
    Carollo, S
    Eagan, M
    Foster, D
    Haldeman, BA
    Hammond, A
    Haugen, H
    Jelinek, L
    Kelly, JD
    Madden, K
    Maurer, MF
    Parrish-Novak, J
    Prunkard, D
    Sexson, S
    Sprecher, C
    Waggie, K
    West, J
    Whitmore, TE
    Yao, L
    Kuechle, MK
    Dale, BA
    Chandrasekher, YA
    [J]. CELL, 2001, 104 (01) : 9 - 19
  • [2] Demoulin JB, 1996, MOL CELL BIOL, V16, P4710
  • [3] Human interleukin-10-related T cell-derived inducible factor: Molecular cloning and functional characterization as an hepatocyte-stimulating factor
    Dumoutier, L
    Van Roost, E
    Colau, D
    Renauld, JC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (18) : 10144 - 10149
  • [4] Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9
    Dumoutier, L
    Louahed, J
    Renauld, JC
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (04) : 1814 - 1819
  • [5] Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22
    Dumoutier, L
    Lejeune, D
    Colau, D
    Renauld, JC
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (12) : 7090 - 7095
  • [6] Stroke: Treatment, prevention and rehabilitation - Perugia 1st International Stroke Meeting, Perugia, Italy, November 26-27, 1999 - Preface
    Gallai, V
    Parnetti, L
    [J]. CEREBROVASCULAR DISEASES, 2000, 10 : 1 - 1
  • [7] Jiang HP, 1995, ONCOGENE, V11, P2477
  • [8] The melanoma differentiation associated gene mda-7 suppresses cancer cell growth
    Jiang, HP
    Su, ZZ
    Lin, JJ
    Goldstein, NI
    Young, CSH
    Fisher, PB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (17) : 9160 - 9165
  • [9] Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri
    Knappe, A
    Hör, S
    Wittmann, S
    Fickenscher, H
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (08) : 3881 - 3887
  • [10] Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity
    Kotenko, SV
    Izotova, LS
    Mirochnitchenko, OV
    Esterova, E
    Dickensheets, H
    Donnelly, RP
    Pestka, S
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (12) : 7096 - 7103